Table 2.
Effect of LXR ligand on genes involved in lipid metabolism in PPARc-deficient mouse liver.
Gene |
PparγWT |
Pparγ∆H |
||||||
---|---|---|---|---|---|---|---|---|
OB/OB |
ob/ob |
OB/OB |
ob/ob |
|||||
Control | T0901317 | Control | T0901317 | Control | T0901317 | Control | T0901317 | |
PPARc | 1.0 ± 0.03 | 0.96 ± 0.04 | 1.0 ± 0.04 | 0.98 ± 0.02 | N.D. | N.D. | 1.0 ± 0.13 | 1.1 ± 0.04 |
LXRa | 1.0 ± 0.04 | 0.67 ± 0.01** | 1.0 ± 0.03 | 0.52 ± 0.01*** | 1.0 ± 0.07 | 0.84 ± 0.02* | 1.0 ± 0.05 | 0.54 ± 0.02** |
ChREBP | 1.0 ± 0.07 | 1.3 ± 0.05* | 1.0 ± 0.03 | 1.0 ± 0.01 | 1.0 ± 0.02 | 1.6 ± 0.01*** | 1.0 ± 0.06 | 0.95 ± 0.04 |
SREBP-1c | 1.0 ± 0.02 | 2.0 ± 0.10* | 1.0 ± 0.02 | 1.0 ± 0.03 | 1.0 ± 0.03 | 2.5 ± 0.21* | 1.0 ± 0.03 | 1.6 ± 0.05* |
Fas | 1.0 ± 0.05 | 11 ± 0.21*** | 1.0 ± 0.09 | 3.1 ± 0.14** | 1.0 ± 0.16 | 10 ± 0.10*** | 1.0 ± 0.07 | 5.3 ± 0.17*** |
Scd1 | 1.0 ± 0.02 | 8.2 ± 0.49*** | 1.0 ± 0.06 | 2.7 ± 0.05*** | 1.0 ± 0.02 | 8.4 ± 0.45*** | 1.0 ± 0.04 | 3.8 ± 0.11*** |
Gpat | 1.0 ± 0.05 | 3.6 ± 0.07*** | 1.0 ± 0.03 | 2.4 ± 0.04*** | 1.0 ± 0.03 | 4.0 ± 0.03*** | 1.0 ± 0.10 | 4.3 ± 0.05*** |
Lpk | 1.0 ± 0.04 | 0.66 ± 0.01** | 1.0 ± 0.05 | 0.89 ± 0.04 | 1.0 ± 0.07 | 1.4 ± 0.05*** | 1.0 ± 0.09 | 1.0 ± 0.03 |
Ap2 | 1.0 ± 0.01 | 1.7 ± 0.33* | 1.0 ± 0.06 | 1.6 ± 0.04** | 1.0 ± 0.02 | 1.7 ± 0.14** | 1.0 ± 0.06 | 1.4 ± 0.04** |
CD36 | 1.0 ± 0.08 | 5.9 ± 0.05*** | 1.0 ± 0.04 | 0.9 ± 0.10 | 1.0 ± 0.03 | 6.1 ± 0.14*** | 1.0 ± 0.00 | 1.2 ± 0.01*** |
Each group is from 3 mice. PparγWT, wild type PPARγ mice; Pparγ∆H, hepatocyte-specific PPARγ null mice ChREBP, carbohydrate response element-binding protein; SREBP-1c, sterol regulatory element-binding protein-1c; Fas, fatty acid synthase; Scd1, stearoyl-CoA desaturase 1; Lpk, liver-type pyruvate kinase; Gpat, glycerol-3-phosphate acyltransferase; Ap2, adipocyte fatty acid-binding protein; CD36, class B scavenger receptor. N.D., not detected. Values are mean ± SE.
p < 0.05.
p < 0.01.
p < 0.001 versus control without T0901317.